Clinical Video Shorts
Omega-3 and Omega-6, Blood Levels And Coronary Heart Disease Risk/Benefit Controversy
Robert Superko, MD and Michael Caulfield, PhD, discuss the current clinical research on the use of Omega-3 & 6 supplementation and their link to decreased risk of cardiovascular events, including sudden cardiac death. They also discuss the clinical management of patients including the use of the Omega-3 & 6, Fatty Acid laboratory test as a marker of cardiovascular risk.
H. Robert Superko, MD, FACC, FAHA, FAACVPR
Academic Associate and Senior Medical Advisor
Quest Diagnostics
Michael P. Caulfield, PhD
Senior Scientific Director,
Endocrinology and Cardiovascular Disease
Quest Diagnostics, Nichols Institute
